SCHEMBL7611054

SCHEMBL7611054

O=C1C(=NO)c2ccccc2N1Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.66
MAPT P10636 4/20 0.66
NPSR1 Q6W5P4 2/20 0.66
TSHR P16473 2/20 0.66
HSD17B10 Q99714 2/20 0.66
LRRK2 Q5S007 1/20 0.66
PKM P14618 1/20 0.66
CES1 P23141 4/20 0.64
ALDH2 P05091 3/20 0.64
ALDH3A1 P30838 3/20 0.64
CHRM1 P11229 2/20 0.64
CA2 P00918 3/20 0.57
CA12 O43570 2/20 0.57
CA9 Q16790 2/20 0.57
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
CA1 P00915 2/20 0.54
CA4 P22748 1/20 0.54
CA7 P43166 1/20 0.54
ACHE P22303 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7611051 1.00 ALDH1A1 (0.66) ALDH1A1MAPTNPSR1TSHRHSD17B10
SCHEMBL9589000 0.91 ALDH1A1 (0.69) ALDH1A1MAPTNPSR1TSHRHSD17B10
SCHEMBL9588997 0.91 ALDH1A1 (0.69) ALDH1A1MAPTNPSR1TSHRHSD17B10
SCHEMBL13627881 0.90 CES1 (0.67) ALDH1A1MAPTNPSR1TSHRHSD17B10
SCHEMBL13627885 0.89 ALDH1A1 (0.54) ALDH1A1MAPTNPSR1TSHRHSD17B10
SCHEMBL13627880 0.88 ALDH1A1 (0.70) ALDH1A1MAPTNPSR1TSHRHSD17B10
SCHEMBL13627894 0.88 LMNA (0.59) ALDH1A1MAPTNPSR1TSHRHSD17B10
SCHEMBL13627896 0.85 ALDH1A1 (0.53) ALDH1A1MAPTNPSR1TSHRHSD17B10
SCHEMBL13627897 0.85 UBE2N (0.63) ALDH1A1MAPTNPSR1TSHRHSD17B10
SCHEMBL13627950 0.85 MAPT (0.59) ALDH1A1MAPTNPSR1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0685463-B1 INDOLIN-2-ONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2002-05-22 EP disclosed
US-6207836-B1 Indolin-2-one derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2001-03-27 US disclosed
US-6127544-A 1-SUBSTITUTED-3-UREIDO-INDOLIN-2-ONES WHICH EXHIBIT SELECTIVE ANTAGONISM AGAINST GASTRIN RECEPTORS WITHOUT CAUSING SIDE EFFECTS ATTRIBUTED TO CCK-A RECEPTOR ANTAGONISM; SUCH AS FOR TREATMENT OF PEPTIC ULCERS, GASTRITIS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-10-03 US disclosed
US-6114536-A ANTAGONISM AGAINST GASTRIN RECEPTORS WITHOUT CAUSING SIDE EFFECTS ATTRIBUTED TO CCK-A RECEPTOR ANTAGONISM AND ARE USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES OF DIGESTIVE ORGANS, SUCH AS PEPTIC ULCER, GASTRITIS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-09-05 US disclosed
US-6031111-A Indolin-2-one derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-02-29 US disclosed
CN-1046268-C Indolin-2-one derivatives CHUGAI PHARMACEUTICAL CO LTD (JP) 1999-11-10 CN disclosed
US-5952511-A EXHIBITS SELECTIVE ANTAGONISM AGAINST GASTRIN RECEPTOR WITHOUT CAUSING SIDE EFFECTS ATTRIBUTED TO GASTRIN RECEPTOR ANTAGONISM AND USEFUL FOR TREATING PEPTIC ULCER, GASTRITIS, REFLUX ESOPHAGITIS AND ZOLLINGER-ELLISON SYNDROME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1999-09-14 US disclosed
EP-0685463-A1 INDOLIN-2-ONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1995-12-06 EP disclosed